Mallinckrodt plc
MCD.DE
€0.180 -77.34% Quote
Exchange Deutsche Börse Sector Healthcare Industry Drug Manufacturers - Specialty & Generic
Q1 2026
Reported
Published: May 12, 2026

Data: Financial Modeling Prep

Company Status Snapshot

Fast view of the latest quarter outcome for MCD.DE

Report Date

May 12, 2026

Quarter Q1 2026

Revenue

468.30M

YoY: -8.9%

EPS

-2.87

YoY: -30.5%

Market Move

-77.34%

Previous quarter: Q1 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Gross Margin

39.8%

Net Income

-113.50M

YoY: -162.1%

N/A

MCD.DE
Company MCD.DE

Swipe to view all report sections

Executive Summary

Mallinckrodt plc reported Q1 2026 revenue of $468.3 million with a gross profit of $186.6 million, delivering a gross margin of 39.85%. Despite topline activity, the quarter produced an operating loss of $113.5 million and a net loss of $113.5 million, with an EPS of -$2.87. The sequential performance shows a sizable QoQ revenue uptick (~11.5%), but profitability remains under pressure due to a high cost base and interest expense, leaving little room for margin expansion in the near term. The trailing four-quarter view highlights volatility in profitability, including a pronounced one-off strength in 2024 Q4 that did not persist into 2025–2026, underscoring execution risk and the sensitivity of the business to fixed costs and financing expenses.

Key Performance Indicators

Revenue
Decreasing
468.30M
QoQ: 11.53% | YoY: -8.94%
Gross Profit
Decreasing
186.60M
39.85% margin
QoQ: -8.03% | YoY: -4.31%
Operating Income
Decreasing
-113.50M
QoQ: -856.67% | YoY: -514.23%
Net Income
Decreasing
-113.50M
QoQ: -309.75% | YoY: -162.12%
EPS
Decreasing
-2.87
QoQ: -103.55% | YoY: -30.45%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 468.30 -2.87 -8.9% View
Q1 2025 419.90 -1.41 -11.6% View
Q4 2024 505.80 123.39 +19.1% View
Q3 2024 505.50 -1.33 +3.0% View